Sally Y. To
Pokfulam Road
Hong Kong, HCW, Hong Kong Special Administrative Region
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Emerging perspectives on metabolic reprogramming in the microenvironment of ovarian cancer metastasis.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: October 21, 2025
Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype.
Journal: Cell death & disease
Published: July 25, 2025
Exosomes in cancer nanomedicine: biotechnological advancements and innovations.
Journal: Molecular cancer
Published: March 31, 2025
Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis.
Journal: Protein & cell
Published: August 27, 2024
Experimental models for ovarian cancer research.
Journal: Experimental cell research
Published: January 14, 2022
p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector.
Journal: Cancer letters
Published: November 26, 2021
A Selective β-Catenin-Metadherin/CEACAM1-CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor-Macrophage Interaction.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 27, 2021
Hypoxia-induced Nur77 activates PI3K/Akt signaling via suppression of Dicer/let-7i-5p to induce epithelial-to-mesenchymal transition.
Journal: Theranostics
Published: August 19, 2020
Substrates with patterned topography reveal metastasis of human cancer cells.
Journal: Biomedical materials (Bristol, England)
Published: August 22, 2017
Nur77: a potential therapeutic target in cancer.
Journal: Expert opinion on therapeutic targets
Published: April 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026